<bill session="118" type="s" number="765" updated="2025-11-19T04:20:40Z">
  <state datetime="2023-03-09">REFERRED</state>
  <status>
    <introduced datetime="2023-03-09"/>
  </status>
  <introduced datetime="2023-03-09"/>
  <titles>
    <title type="display">Reducing Hereditary Cancer Act of 2023</title>
    <title type="official" as="introduced">A bill to amend title XVIII of the Social Security Act to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer.</title>
    <title type="short" as="introduced">Reducing Hereditary Cancer Act of 2023</title>
  </titles>
  <sponsor bioguide_id="M001153"/>
  <cosponsors>
    <cosponsor bioguide_id="C000141" joined="2023-03-09"/>
    <cosponsor bioguide_id="P000595" joined="2024-11-12"/>
  </cosponsors>
  <actions>
    <action datetime="2023-03-09">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2023-03-09" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills>
    <bill session="118" type="h" number="1526" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Cancer"/>
    <term name="Genetics"/>
    <term name="Health care coverage and access"/>
    <term name="Health promotion and preventive care"/>
    <term name="Hereditary and development disorders"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Medicare"/>
  </subjects>
  <amendments/>
  <summary date="2023-04-04T13:31:08Z" status="Introduced in Senate">Reducing Hereditary Cancer Act of 2023

This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.</summary>
</bill>
